Doximity, Inc. (DOCS) Fair Value 2026

DOCS · Health Information Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

9.6 /10

32 fundamental signals · 9 models active

Value Trap Risk

LOW (28/100)

Quick Summary — As of 2026-10-07, Doximity, Inc. (DOCS) trades at $27.79, versus a $27.76 median fair value across its 9 active models — 0.1% below the current price. QOC: 9.6/10. Value Trap Risk: 28/100 (LOW). 9/13 models active. Within that set, the Bayesian DCF component alone returns $34.79.

Key Facts

Ticker
DOCS
Price
$27.79
Quality Score
9.6/10
Value Trap Risk
28/100
Models Active
9/13
Last Updated
Strength: Bayesian DCF suggests +25.2% upside with 65% confidence
Risk: Limited model coverage (9/13) may reduce confidence

Is Doximity, Inc. (DOCS) Undervalued or Overvalued in 2026?

According to CirclFi’s 9-model valuation engine, Doximity, Inc. (DOCS) appears fairly valued as of : the median of 9 independent fair value estimates is $27.76, essentially in line with the current price of $27.79. Estimates range from $3.22 to $87.19. DOCS scores 9.6/10 on fundamental quality and 28/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -20.1% versus its own 13-model consensus, across 3,777 rated companies as of 2026-10-07. DOCS’s -0.1% gap is narrower than that market norm, and the Health Information Services sector median is +1.2%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Doximity, Inc. Stock in 2026? →

What Fair Value Does Each Model Give DOCS?

9 Intrinsic Value Models vs. Current Price ($27.79)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $34.79 +25.2%
Ensemble · Low Conviction
 $25.88 -6.9%
Scenario · High Conviction
 $32.17 +15.8%
Intrinsic · High Conviction
 $9.38 -66.3%
Unlock the Full Matrix

Access 5 additional models including ML-RIV, Regime Cross-Sectional, and more.

$2 / day

Billed monthly ($60/mo) or annually ($299/yr)

Unlock All 9 Models →

Cancel anytime · No contracts · Instant access

What Is DOCS's Fair Value Range?

Spread across 9 independent models · $3.22 to $87.19

CirclFi's 9 active models place Doximity, Inc. (DOCS) between $3.22 and $87.19 per share, a spread of 302% of the median. The median of that range — $27.76 — is the fair value CirclFi publishes for DOCS, against a current price of $27.79.

Low · ML-RIVHigh · Regime Cross
$3.22median $27.76$87.19
Where the range comes from
Most bearish modelML Residual Income$3.22
Most bullish modelRegime Cross-Sectional$87.19
Model agreement4 bullish · 4 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for DOCS. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on DOCS, not a CirclFi price target. How each model works →

What Is Doximity, Inc. (DOCS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Doximity, Inc.'s intrinsic value is estimated at a median $27.76, showing conflicting signals at the current price of $27.79. While the median implied return is -0.1%, model disagreement is elevated with a gap of +302.2% between the most bullish and bearish estimates. The most optimistic model, Regime Cross, places fair value at $87.19 (+213.8%), while ML-RIV — the most conservative — estimates $3.22 (-88.4%). This +302.2% gap reflects genuine analytical uncertainty about Doximity, Inc.'s intrinsic worth.

What Do the Models Say About DOCS?

9 of 13 models are currently active for DOCS. Of these, 4 models suggest upside while 5 models suggest overvaluation. Taken together, their median fair value for DOCS is $27.76 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $34.79 on its own, implying +25.2% upside from the current price. See which stocks rank higher →

How Does DOCS Rank in Health Information Services?

Among 53 Health Information Services stocks, DOCS ranks #1 by Quality of Company score. CirclFi's QOC score of 9.6/10 evaluates 32 fundamental signals. A score of 9.6 places DOCS in the top tier.

See all Most Undervalued Health Information Services Stocks →

Doximity, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is DOCS a Value Trap?

CirclFi's Value Trap algorithm assigns DOCS a score of 28/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

9 of 13 models are active for Doximity, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Doximity, Inc.'s fundamental quality profile registers 9.6/10. This exceptional score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +302.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every DOCS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across DOCS's 9 active models, average confidence is 45%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Doximity, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Health Information Services Stocks Should You Also Analyze?

9 related Health Information Services stocks with 13-model coverage

ZCMDZhongchao Inc.QOC 1.7HQYHealthEquity, Inc.QOC 9.5MNDRMobile-health Network SolutionsQOC 2.7VEEVVeeva Systems Inc.QOC 9.3ESSIEco Science Solutions, Inc.QOC 3.9HSTMHealthStream, Inc.QOC 8.7OMCLOmnicell, Inc.QOC 7.5CARLCarlsmed, Inc.QOC 6.3MGRXMangoceuticals, Inc.QOC 4.9

Read investment analysis: ZCMD · HQY · MNDR · VEEV · ESSI · HSTM · OMCL · CARL · MGRX

Which Other Stocks Have a Similar Quality Score to DOCS?

7 companies across all industries closest to DOCS’s Quality of Company score of 9.6/10.

BKTIBK Technologies CorporationQOC 9.6UTHRUnited Therapeutics CorporationQOC 9.6MANHManhattan Associates, Inc.QOC 9.6GOOGAlphabet Inc.QOC 9.6FFIVF5, Inc.QOC 9.6FIXComfort Systems USA, Inc.QOC 9.6NVDANVIDIA CorporationQOC 10.0

Read investment analysis: BKTI · UTHR · MANH · GOOG · FFIV · FIX · NVDA

Where Does DOCS Sit in CirclFi's Health Information Services Rankings?

DOCS is ranked against every other Health Information Services stock CirclFi covers in each of these screens.

See all Health Information Services stocks ranked →

What Else Do Investors Ask About Doximity, Inc.’s Valuation?

What is Doximity, Inc.'s intrinsic value in 2026?

CirclFi puts Doximity, Inc. (DOCS)'s intrinsic value at $27.76 — the median of 9 independent model estimates as of 2026-10-07, ranging from $3.22 to $87.19. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $34.79 on its own. The Quality of Company score is 9.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is DOCS overvalued or undervalued right now?

At $27.79, 4 of 9 active models suggest DOCS may be undervalued, while 5 indicate potential overvaluation. The median of all 9 fair value estimates is $27.76, essentially in line with the current price of $27.79 — a consensus view that DOCS is fairly valued. The assessment depends on which methodology best fits Doximity, Inc.'s business model in Health Information Services.

What does a Quality of Company score of 9.6 mean for DOCS?

Doximity, Inc.'s QOC of 9.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on DOCS?

CirclFi analyzes DOCS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 9 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on DOCS?

Of the 9 models currently active on DOCS, Regime Cross-Sectional is the most bullish at $87.19 per share, and ML Residual Income is the most bearish at $3.22. CirclFi's published fair value for DOCS is the median of that range, $27.76, not either extreme. The gap between the two ends equals 302% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is DOCS a value trap in 2026?

Doximity, Inc.'s Value Trap score is 28/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 9-model valuation engine, Doximity, Inc. (DOCS) has a median fair value of $27.76 — essentially in line with the current price of $27.79 — as of 2026-10-07.” Source: circlfi.com/stock/DOCS/ · Methodology
Primary sources for this DOCS valuation
  • Financial statements: Doximity, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001516513) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for DOCS as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 9 mathematical frameworks give you clarity on DOCS.

Unlock All 9 Fair Values — $60/mo

Cancel anytime · Less than a cup of coffee · Instant access

5 models hidden for DOCS Unlock All 9 — $60/mo